• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症患者自噬和噬线粒体标志与 ANT1 和 NFL 的关系。

The relationship between ANT1 and NFL with autophagy and mitophagy markers in patients with multiple sclerosis.

机构信息

Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Clinical Biochemistry and Laboratory Medicine, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Department of Biochemistry, Faculty of Biological Science, Tarbiat Modares University, Tehran, Iran.

出版信息

J Clin Neurosci. 2020 Aug;78:307-312. doi: 10.1016/j.jocn.2020.04.122. Epub 2020 May 4.

DOI:10.1016/j.jocn.2020.04.122
PMID:32376155
Abstract

Multiple sclerosis (MS) is the most common inflammatory neurodegenerative disease. Neurofilament light chain (NFL) is a novel adverting biomarker of axonal damage that suggested as a useful assistant in the monitoring of MS patients. It has been shown that the auto/mitophagy associated with MS pathogenesis. In this study, we aimed to study correlation between ATG5 and Parkin, as markers of autophagy and mitophagy respectively, with NFL and ANT1 in serum and cerebrospinal fluid (CSF) in MS subjects. ATG5, Parkin, NFL, and ANT1 levels were measured in a cross-sectional study of 40 MS patients compared with gender, age and BMI matching healthy volunteers. Based on our results, levels of ATG5, Parkin, and NFL significantly were elevated in both serum and CSF of MS patients comparing control individuals (p < 0.0001) but ANT1 levels significantly was decreased in both serum and CSF of MS patients comparing control individuals (p < 0.0001). The correlation indices between NFL, ANTI1, ATG5 and Parkin in both case and control groups showed a direct and moderate the correlation between ANTI1 and ATG5 in the CSF level of the control group (r = 0.554, P = 0.011). Our data support the feasibility of quantifying of NFL as a sensitive and clinically meaningful serum/CSF biomarker to follow-up nerve tissue injury in MS condition.

摘要

多发性硬化症(MS)是最常见的炎症性神经退行性疾病。神经丝轻链(NFL)是一种新型的轴突损伤的预测生物标志物,被认为是监测 MS 患者的有用辅助手段。已经表明,与 MS 发病机制相关的自噬/线粒体自噬。在这项研究中,我们旨在研究 ATG5 和 Parkin 分别作为自噬和线粒体自噬的标志物与 MS 患者血清和脑脊液(CSF)中的 NFL 和 ANT1 之间的相关性。在一项横断面研究中,我们测量了 40 名 MS 患者和性别、年龄和 BMI 匹配的健康志愿者的血清和 CSF 中的 ATG5、Parkin、NFL 和 ANT1 水平。与对照组相比,MS 患者的血清和 CSF 中 ATG5、Parkin 和 NFL 水平显著升高(p<0.0001),但 ANT1 水平显著降低(p<0.0001)。病例组和对照组中 NFL、ANT1、ATG5 和 Parkin 之间的相关指数显示,对照组 CSF 水平中 ANTI1 和 ATG5 之间存在直接和中度的相关性(r=0.554,P=0.011)。我们的数据支持将 NFL 定量作为一种敏感和有临床意义的血清/CSF 生物标志物来监测 MS 患者神经组织损伤的可行性。

相似文献

1
The relationship between ANT1 and NFL with autophagy and mitophagy markers in patients with multiple sclerosis.多发性硬化症患者自噬和噬线粒体标志与 ANT1 和 NFL 的关系。
J Clin Neurosci. 2020 Aug;78:307-312. doi: 10.1016/j.jocn.2020.04.122. Epub 2020 May 4.
2
Evaluation of the Diagnostic and Predictive Value of Serum Levels of ANT1, ATG5, and Parkin in Multiple Sclerosis.评价血清 ANT1、ATG5 和 Parkin 水平在多发性硬化症中的诊断和预测价值。
Clin Neurol Neurosurg. 2020 Oct;197:106197. doi: 10.1016/j.clineuro.2020.106197. Epub 2020 Aug 29.
3
Evaluating the utility of serum NfL, GFAP, UCHL1 and tTAU as estimates of CSF levels and diagnostic instrument in neuroinflammation and multiple sclerosis.评估血清 NfL、GFAP、UCHL1 和 tTAU 作为神经炎症和多发性硬化症中 CSF 水平和诊断工具的估计值的效用。
Mult Scler Relat Disord. 2024 Jul;87:105644. doi: 10.1016/j.msard.2024.105644. Epub 2024 Apr 26.
4
Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis.多发性硬化症随访期间的神经丝水平、疾病活动和脑容量。
J Neuroinflammation. 2018 Jul 18;15(1):209. doi: 10.1186/s12974-018-1249-7.
5
Monitoring disease activity in multiple sclerosis using serum neurofilament light protein.使用血清神经丝轻链蛋白监测多发性硬化症的疾病活动
Neurology. 2017 Nov 28;89(22):2230-2237. doi: 10.1212/WNL.0000000000004683. Epub 2017 Oct 27.
6
Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis.血清和脑脊液中的神经丝轻链及针对它们的抗体在临床孤立综合征和多发性硬化中的研究。
J Neuroimmunol. 2013 Sep 15;262(1-2):113-20. doi: 10.1016/j.jneuroim.2013.06.010. Epub 2013 Jul 17.
7
Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa.三种分析平台用于定量血液样本中神经丝轻链的比较:酶联免疫吸附测定(ELISA)、电化学发光免疫测定和单分子阵列检测技术(Simoa)
Clin Chem Lab Med. 2016 Oct 1;54(10):1655-61. doi: 10.1515/cclm-2015-1195.
8
Correlation between auto/mitophagic processes and magnetic resonance imaging activity in multiple sclerosis patients.多发性硬化症患者的自噬/线粒体自噬过程与磁共振成像活动之间的相关性。
J Neuroinflammation. 2019 Jun 27;16(1):131. doi: 10.1186/s12974-019-1526-0.
9
Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod.多发性硬化症患者从注射治疗改为芬戈莫德后血浆神经丝轻链水平。
Mult Scler. 2018 Jul;24(8):1046-1054. doi: 10.1177/1352458517715132. Epub 2017 Jun 19.
10
Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis.与多发性硬化症轴突损伤相关的脑脊液免疫生物标志物。
Eur J Neurol. 2015 Aug;22(8):1169-75. doi: 10.1111/ene.12579. Epub 2014 Oct 17.

引用本文的文献

1
Cell death in multiple sclerosis.多发性硬化症中的细胞死亡
Cell Death Differ. 2025 Sep 9. doi: 10.1038/s41418-025-01576-7.
2
The role of autophagy in the pathogenesis and treatment of multiple sclerosis.自噬在多发性硬化症发病机制及治疗中的作用
Autophagy Rep. 2025 Jul 22;4(1):2529196. doi: 10.1080/27694127.2025.2529196. eCollection 2025.
3
Pathogenetic Involvement of Autophagy and Mitophagy in Primary Progressive Multiple Sclerosis.自噬和线粒体自噬在原发性进行性多发性硬化症中的发病机制参与
J Cell Mol Med. 2025 Apr;29(8):e70455. doi: 10.1111/jcmm.70455.
4
Anti-inflammatory, antioxidant and anti-mitophagy effects of trans sodium crocetinate on experimental autoimmune encephalomyelitis in BALB/C57 mice.反式-对甲苯磺酸钠 crocetinate 对实验性自身免疫性脑脊髓炎 BALB/C57 小鼠的抗炎、抗氧化和抗自噬作用。
Metab Brain Dis. 2024 Jun;39(5):783-801. doi: 10.1007/s11011-024-01349-0. Epub 2024 May 13.
5
Interactions Between Extracellular Vesicles and Autophagy in Neuroimmune Disorders.细胞外囊泡与神经免疫紊乱中的自噬相互作用
Neurosci Bull. 2024 Jul;40(7):992-1006. doi: 10.1007/s12264-024-01183-5. Epub 2024 Feb 29.
6
The beneficial role of autophagy in multiple sclerosis: Yes or No?自噬在多发性硬化症中的有益作用:是还是否?
Autophagy. 2024 Feb;20(2):259-274. doi: 10.1080/15548627.2023.2259281. Epub 2023 Sep 15.
7
The complexities of investigating mitochondria dynamics in multiple sclerosis and mouse models of MS.在多发性硬化症及多发性硬化症小鼠模型中研究线粒体动力学的复杂性。
Front Neurosci. 2023 Jul 25;17:1144896. doi: 10.3389/fnins.2023.1144896. eCollection 2023.
8
Targeting mitophagy for neurological disorders treatment: advances in drugs and non-drug approaches.针对线粒体自噬治疗神经疾病:药物及非药物方法的进展
Naunyn Schmiedebergs Arch Pharmacol. 2023 Dec;396(12):3503-3528. doi: 10.1007/s00210-023-02636-w. Epub 2023 Aug 3.
9
Emerging imaging and liquid biomarkers in multiple sclerosis.多发性硬化症中的新兴影像和液体生物标志物。
Eur J Immunol. 2023 Aug;53(8):e2250228. doi: 10.1002/eji.202250228. Epub 2023 May 28.
10
An Update on Diagnostic Laboratory Biomarkers for Multiple Sclerosis.多发性硬化症诊断实验室生物标志物的最新进展。
Curr Neurol Neurosci Rep. 2022 Oct;22(10):675-688. doi: 10.1007/s11910-022-01227-1. Epub 2022 Oct 21.